Fospropofol disodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for fospropofol disodium and what is the scope of patent protection?
Fospropofol disodium
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for fospropofol disodium
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 20 |
Patent Applications: | 10 |
DailyMed Link: | fospropofol disodium at DailyMed |
Recent Clinical Trials for fospropofol disodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Xiaobo Yang, MD | Phase 2 |
Wuhan Union Hospital, China | Phase 2 |
Mayo Clinic | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for fospropofol disodium
US Patents and Regulatory Information for fospropofol disodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for fospropofol disodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |